Skip to main content
HOUSE 941117th CongressBecame Public Law No: 117-15.

TRANSPLANT Act of 2021

Last Action
5/26/2021

Actions

  • 2021-05-26Became Public Law No: 117-15.
  • 2021-05-26Became Public Law No: 117-15.
  • 2021-05-26Signed by President.
  • 2021-05-26Signed by President.
  • 2021-05-20Presented to President.
  • 2021-05-20Presented to President.
  • 2021-05-18Message on Senate action sent to the House.
  • 2021-05-17Passed Senate without amendment by Voice Vote.
  • 2021-05-17Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
  • 2021-05-17Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)
  • 2021-05-17Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)
  • 2021-04-19Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • 2021-04-15Motion to reconsider laid on the table Agreed to without objection.
  • 2021-04-15On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)
  • 2021-04-15Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).(text: 04/14/2021 CR H1752-1753)

Showing 15 of 20 actions. Full history on Congress.gov.

CRS Summary

As of 2021-05-26 (49)

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Cosponsors (20)

  • Gus Bilirakis (R-FL)
  • Chellie Pingree (D-ME)
  • Richard Hudson (R-NC)
  • Julia Brownley (D-CA)
  • G. K. Butterfield (D-NC)
  • Brian Fitzpatrick (R-PA)
  • Mary Scanlon (D-PA)
  • Tom Emmer (R-MN)
  • Pete Aguilar (D-CA)
  • BOBBY RUSH (D-IL)
  • Kurt Schrader (D-OR)
  • GRACE NAPOLITANO (D-CA)
  • Angie Craig (D-MN)
  • Judy Chu (D-CA)
  • Madeleine Dean (D-PA)
  • David Trone (D-MD)
  • Jahana Hayes (D-CT)
  • Mondaire Jones (D-NY)
  • Eric Swalwell (D-CA)
  • Tom McClintock (R-CA)

Became law: Pub. L. 117-15

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.